SCHEMBL11985512

SCHEMBL11985512

CC(C)(C)C(=O)c1ccccc1-c1ncc[nH]1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.68
TYRO3 Q06418 1/20 0.68
DYRK1B Q9Y463 1/20 0.68
HCRTR1 O43613 2/20 0.46
HCRTR2 O43614 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
NISCH Q9Y2I1 2/20 0.43
MTOR P42345 1/20 0.43
ADK P55263 1/20 0.43
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 2/20 0.41
IDO1 P14902 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
PARP1 P09874 1/20 0.39
EDNRA P25101 1/20 0.38
ADRB3 P13945 1/20 0.38
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15478263 0.84 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL10714674 0.83 CSNK1A1 (0.76) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL30965100 0.82 CSNK1A1 (0.73) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL297622 0.82 CSNK1A1 (0.73) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL11566235 0.81 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
Hydrochloric Acid SCHEMBL5854599 0.81 CSNK1A1 (0.71) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL6825869 0.81 CSNK1A1 (1.00) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL12892036 0.80 CSNK1A1 (0.66) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
SCHEMBL8781273 0.80 CSNK1A1 (0.66) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2
Water SCHEMBL30473073 0.79 CSNK1A1 (0.97) CSNK1A1TYRO3DYRK1BHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653260-B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2014-02-18 US disclosed
US-8399480-B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-03-19 US disclosed
US-20120258963-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. 2012-10-11 US disclosed
US-8247415-B2 Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists MERCK SHARP & DOHME CORP. (US) 2012-08-21 US disclosed
US-20110028481-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. 2011-02-03 US disclosed
US-20090253705-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME LLC 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028481-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885
US-20120258963-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885
US-20090253705-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS ADRB3, ADRB1, ADRB2 CSNK1A1 1793/4885TYRO3 1201/4885DYRK1B 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.